Levosulpiride_[Inn]
Category
Levosulpiride_[Inn] Brand names, Levosulpiride_[Inn] Analogs
Levosulpiride_[Inn] Brand Names Mixture
No information avaliable
Levosulpiride_[Inn] Chemical_Formula
C15H23N3O4S
Levosulpiride_[Inn] RX_link
No information avaliable
Levosulpiride_[Inn] fda sheet
Levosulpiride_[Inn] msds (material safety sheet)
Levosulpiride_[Inn] Synthesis Reference
No information avaliable
Levosulpiride_[Inn] Molecular Weight
341.427 g/mol
Levosulpiride_[Inn] Melting Point
178 oC
Levosulpiride_[Inn] H2O Solubility
2280 mg/L
Levosulpiride_[Inn] State
Solid
Levosulpiride_[Inn] LogP
1.337
Levosulpiride_[Inn] Dosage Forms
Tablet
Levosulpiride_[Inn] Indication
Sulpiride is indicated for the treatment of schizophrenia.
Levosulpiride_[Inn] Pharmacology
Sulpiride is a substituted benzamide derivative and a selective dopamine D2 antagonist with antipsychotic and antidepressant activity. Other benzamide derivatives include metoclopramide, tiapride, and sultopride.
Levosulpiride_[Inn] Absorption
No information avaliable
Levosulpiride_[Inn] Toxicity
No information avaliable
Levosulpiride_[Inn] Patient Information
No information avaliable
Levosulpiride_[Inn] Organisms Affected
Humans and other mammals